Saint Priest En Jarez, France Clinical Trials

A listing of Saint Priest En Jarez, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 105 clinical trials
National Register of Oesophageal Atresia

The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...). The current prognosis for this ailment is good. However he persists a …

HFME de Lyon
 (31.3 away) Contact site
  • 4 views
  • 08 May, 2021
  • +46 other locations
Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves

Validate the use of fetal urine peptidome-analysis and explore amniotic fluid markers for the stratification of fetuses with Posterior Urethral Valve for post-natal renal function.

CHU H pitaux de St-Etienne-H pital Nord
 (2.4 away) Contact site
  • 16 views
  • 27 Jan, 2021
  • +32 other locations
Efficacy of Colonoscopy Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening

Efficacy of colonoscopy, colon capsule and fecal immunological test for colorectal cancer screening, in first degree relatives of patients with colorectal neoplasia: a prospective randomized study.

colorectal cancer screening
cancer screening
endoscopy
CHU de Saint-Etienne - H pital nord
 (0.5 away) Contact site
  • 30 views
  • 17 Feb, 2021
  • +28 other locations
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice

advate
antihemophilic factor
CIC
 (0.5 away) Contact site
  • 169 views
  • 21 May, 2021
  • +180 other locations
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

This post authorization safety study is designed as prospective non interventional study for patients with newly diagnosed multiple myeloma who are not eligible for transplant. The objective is to compare the incidence of cardiovascular events between patients treated with a first-line lenalidomide containing regimen and those treated with a first-line …

revlimid
cancer
lenalidomide
Centre Hospitalier Universitaire (CHU) de Saint-Etienne - Hopital Nord
 (0.5 away) Contact site
  • 170 views
  • 26 Mar, 2021
  • +161 other locations
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

The purpose of this study is to monitor the long-term safety of ustekinumab in pediatric participants (6 years to 17 years of age at the time of inclusion) with moderate to severe plaque psoriasis, through monitoring for the following adverse events potentially related to immune modulation: serious infections, malignancies and …

plaque psoriasis
body mass index
cancer
autoimmune disease
ustekinumab
CHU Saint-Etienne - H pital Nord
 (2.4 away) Contact site
  • 50 views
  • 15 Jul, 2021
  • +47 other locations
Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge …

 (2.4 away) Contact site
  • 24600 views
  • 25 Jul, 2021
  • +402 other locations
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE

The treatment of the venous thromboembolic disease, including pulmonary embolism (PE), is based on anticoagulants. During the last decade, all the randomized clinical trials evaluating these anticoagulants have included PE patients with an average age below 60 years. But in clinical pratice, approximately 50% of PE patients are older than …

anticoagulants
thromboembolism
fondaparinux
vitamin k antagonist
venous thromboembolic disease
CHU de Saint Etienne
 (4.2 away) Contact site
  • 27 views
  • 18 Apr, 2021
  • +24 other locations
Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics

Epidemics and infectious diseases in general, punctuate much of the activity of an emergency service. The impact of winter infections is particularly important to vulnerable populations such as infant during bronchiolitis epidemics and the elderly during seasonal influenza. Each year, these epidemic phenomena lead to disorganization of emergency services and …

renal failure
CHU de Saint Etienne (adult emergency service)
 (8.9 away) Contact site
  • 2 views
  • 02 Feb, 2021
  • +10 other locations
Study of Predictive Factors of Progression of Motor Neurone Disease

Amyotrophic lateral sclerosis (ALS) is a complex polymorph and devastating neurodegenerative disease. Although the pathophysiological mechanisms underlying the development of ALS remain to be fully elucidated, there have been significant advances in the understanding of ALS pathogenesis, with evidence emerging of a complex interaction between genetic factors and dysfunction of …

neurological disorder
spasm
deficit
amyotrophic lateral sclerosis
motor neuron disease
H pital Nord
 (2.4 away) Contact site
  • 23 views
  • 24 Jan, 2021
  • +20 other locations